
- In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats.
- The big story: Trump’s tariff regime is open to compromises.
- The markets: Mixed. Gains in the U.S. and Asia but gloom persists in Europe and S&P futures.
- Analyst notes from Macquarie and Claudia Sahm on Trump and Powell, Goldman Sachs on the dollar, and Nomura on the political effect of cheap Chinese imports.
- Plus: All the news and watercooler chat from Fortune.
Good morning. Pfizer’s Albert Bourla has become a fixture among Fortune 500 CEOs, having run the pharma giant since 2018. Yet Bourla—who trained as a veterinarian and joined Pfizer’s animal health division in 1993—considers himself a scientist first and a businessman second. As he said at a New York Academy of Sciences (NYAS) dinner earlier this week where he was being honored: “Science is the cornerstone of progress in our society.”